InvestorsHub Logo
Followers 0
Posts 484
Boards Moderated 0
Alias Born 10/10/2014

Re: davidal66 post# 345

Tuesday, 06/14/2016 11:30:56 AM

Tuesday, June 14, 2016 11:30:56 AM

Post# of 2099
FDA reviews and verifies the data and will not approve a trial for a number of reasons, including improper (selective) censoring.

The shorts complained about rGBM data and said there was no way it would move to phase 3.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VBLT News